Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
40,091,492
-
Share change
-
-337,224
-
Total reported value
-
$1,701,411,015
-
Put/Call ratio
-
94%
-
Price per share
-
$42.44
-
Number of holders
-
136
-
Value change
-
-$5,525,047
-
Number of buys
-
61
-
Number of sells
-
68
Institutional Holders of ACCELERON PHARMA INC - COMMON STOCK (XLRN) as of Q4 2017
As of 31 Dec 2017,
ACCELERON PHARMA INC - COMMON STOCK (XLRN) was held by
136 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,091,492 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, Vanguard Group Inc, PERCEPTIVE ADVISORS LLC, Novo Holdings A/S, WESTFIELD CAPITAL MANAGEMENT CO LP, STATE STREET CORP, EAGLE ASSET MANAGEMENT INC, and FARALLON CAPITAL MANAGEMENT LLC.
This page lists
136
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.